161 related articles for article (PubMed ID: 34671769)
1. A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses.
Wang P; Casner RG; Nair MS; Yu J; Guo Y; Wang M; Chan JF; Cerutti G; Iketani S; Liu L; Sheng Z; Chen Z; Yuen KY; Kwong PD; Huang Y; Shapiro L; Ho DD
bioRxiv; 2021 Oct; ():. PubMed ID: 34671769
[TBL] [Abstract][Full Text] [Related]
2. A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses.
Wang P; Casner RG; Nair MS; Yu J; Guo Y; Wang M; Chan JF; Cerutti G; Iketani S; Liu L; Sheng Z; Chen Z; Yuen KY; Kwong PD; Huang Y; Shapiro L; Ho DD
Emerg Microbes Infect; 2022 Dec; 11(1):147-157. PubMed ID: 34836485
[TBL] [Abstract][Full Text] [Related]
3. Broad Sarbecovirus Neutralizing Antibodies Obtained by Computational Design and Synthetic Library Screening.
Yang X; Duan H; Liu X; Zhang X; Pan S; Zhang F; Gao P; Liu B; Yang J; Chi X; Yang W
J Virol; 2023 Jul; 97(7):e0061023. PubMed ID: 37367229
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
Jensen JL; Sankhala RS; Dussupt V; Bai H; Hajduczki A; Lal KG; Chang WC; Martinez EJ; Peterson CE; Golub ES; Rees PA; Mendez-Rivera L; Zemil M; Kavusak E; Mayer SV; Wieczorek L; Kannan S; Doranz BJ; Davidson E; Yang ES; Zhang Y; Chen M; Choe M; Wang L; Gromowski GD; Koup RA; Michael NL; Polonis VR; Rolland M; Modjarrad K; Krebs SJ; Joyce MG
J Virol; 2023 Jul; 97(7):e0159622. PubMed ID: 37395646
[TBL] [Abstract][Full Text] [Related]
5. Design of a bifunctional pan-sarbecovirus entry inhibitor targeting the cell receptor and viral fusion protein.
Jin H; Cheng L; Gong Y; Zhu Y; Chong H; Zhang Z; He Y
J Virol; 2023 Aug; 97(8):e0019223. PubMed ID: 37578234
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for broad sarbecovirus neutralization by a human monoclonal antibody.
Tortorici MA; Czudnochowski N; Starr TN; Marzi R; Walls AC; Zatta F; Bowen JE; Jaconi S; di Iulio J; Wang Z; De Marco A; Zepeda SK; Pinto D; Liu Z; Beltramello M; Bartha I; Housley MP; Lempp FA; Rosen LE; Dellota E; Kaiser H; Montiel-Ruiz M; Zhou J; Addetia A; Guarino B; Culap K; Sprugasci N; Saliba C; Vetti E; Giacchetto-Sasselli I; Silacci Fregni C; Abdelnabi R; Caroline Foo SY; Havenar-Daughton C; Schmid MA; Benigni F; Cameroni E; Neyts J; Telenti A; Snell G; Virgin HW; Whelan SPJ; Bloom JD; Corti D; Veesler D; Pizzuto MS
bioRxiv; 2021 Apr; ():. PubMed ID: 33851169
[TBL] [Abstract][Full Text] [Related]
7. Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies.
Jette CA; Cohen AA; Gnanapragasam PNP; Muecksch F; Lee YE; Huey-Tubman KE; Schmidt F; Hatziioannou T; Bieniasz PD; Nussenzweig MC; West AP; Keeffe JR; Bjorkman PJ; Barnes CO
Cell Rep; 2021 Sep; 36(13):109760. PubMed ID: 34534459
[TBL] [Abstract][Full Text] [Related]
8. Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
Zhan W; Tian X; Zhang X; Xing S; Song W; Liu Q; Hao A; Hu Y; Zhang M; Ying T; Chen Z; Lan F; Sun L
J Virol; 2022 Aug; 96(16):e0048022. PubMed ID: 35924918
[TBL] [Abstract][Full Text] [Related]
9. Cross-Neutralization of SARS-CoV-2-Specific Antibodies in Convalescent and Immunized Human Sera against the Bat and Pangolin Coronaviruses.
Srisutthisamphan K; Saenboonrueng J; Wanitchang A; Viriyakitkosol R; Jongkaewwattana A
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016415
[TBL] [Abstract][Full Text] [Related]
10. Novel sarbecovirus bispecific neutralizing antibodies with exceptional breadth and potency against currently circulating SARS-CoV-2 variants and sarbecoviruses.
Wang Y; Liu M; Shen Y; Ma Y; Li X; Zhang Y; Liu M; Yang XL; Chen J; Yan R; Luan D; Wang Y; Chen Y; Wang Q; Lin H; Li Y; Wu K; Zhu T; Zhao J; Lu H; Wen Y; Jiang S; Wu F; Zhou Q; Shi ZL; Huang J
Cell Discov; 2022 Apr; 8(1):36. PubMed ID: 35443747
[TBL] [Abstract][Full Text] [Related]
11. Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2.
Rao X; Zhao R; Tong Z; Guo S; Peng W; Liu K; Li S; Wu L; Tong J; Chai Y; Han P; Wang F; Jia P; Li Z; Zhao X; Li D; Zhang R; Zhang X; Zou W; Li W; Wang Q; Gao GF; Wu Y; Dai L; Gao F
Proc Natl Acad Sci U S A; 2023 Dec; 120(52):e2314193120. PubMed ID: 38109549
[TBL] [Abstract][Full Text] [Related]
12. Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecoviruses.
Ruiz F; Foreman W; Lilly M; Baharani VA; Depierreux DM; Chohan V; Taylor AL; Guenthoer J; Ralph D; Matsen FA; Chu HY; Bieniasz PD; Côté M; Starr TN; Overbaugh J
bioRxiv; 2024 Apr; ():. PubMed ID: 38712126
[TBL] [Abstract][Full Text] [Related]
13. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
[TBL] [Abstract][Full Text] [Related]
14. A Novel Conserved Linear Neutralizing Epitope on the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein.
Hua RH; Zhang SJ; Niu B; Ge JY; Lan T; Bu ZG
Microbiol Spectr; 2023 Aug; 11(4):e0119023. PubMed ID: 37306579
[TBL] [Abstract][Full Text] [Related]
15. Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivor.
Chia WN; Tan CW; Tan AWK; Young B; Starr TN; Lopez E; Fibriansah G; Barr J; Cheng S; Yeoh AY; Yap WC; Lim BL; Ng TS; Sia WR; Zhu F; Chen S; Zhang J; Kwek MSS; Greaney AJ; Chen M; Au GG; Paradkar PN; Peiris M; Chung AW; Bloom JD; Lye D; Lok S; Wang LF
Sci Adv; 2023 Jul; 9(30):eade3470. PubMed ID: 37494438
[TBL] [Abstract][Full Text] [Related]
16. Broad sarbecovirus neutralization by a human monoclonal antibody.
Tortorici MA; Czudnochowski N; Starr TN; Marzi R; Walls AC; Zatta F; Bowen JE; Jaconi S; Di Iulio J; Wang Z; De Marco A; Zepeda SK; Pinto D; Liu Z; Beltramello M; Bartha I; Housley MP; Lempp FA; Rosen LE; Dellota E; Kaiser H; Montiel-Ruiz M; Zhou J; Addetia A; Guarino B; Culap K; Sprugasci N; Saliba C; Vetti E; Giacchetto-Sasselli I; Fregni CS; Abdelnabi R; Foo SC; Havenar-Daughton C; Schmid MA; Benigni F; Cameroni E; Neyts J; Telenti A; Virgin HW; Whelan SPJ; Snell G; Bloom JD; Corti D; Veesler D; Pizzuto MS
Nature; 2021 Sep; 597(7874):103-108. PubMed ID: 34280951
[TBL] [Abstract][Full Text] [Related]
17. Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes.
Fan C; Cohen AA; Park M; Hung AF; Keeffe JR; Gnanapragasam PNP; Lee YE; Gao H; Kakutani LM; Wu Z; Kleanthous H; Malecek KE; Williams JC; Bjorkman PJ
Immunity; 2022 Dec; 55(12):2419-2435.e10. PubMed ID: 36370711
[TBL] [Abstract][Full Text] [Related]
18. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
Elife; 2022 Aug; 11():. PubMed ID: 36004719
[TBL] [Abstract][Full Text] [Related]
19. Single domain antibodies derived from ancient animals as broadly neutralizing agents for SARS-CoV-2 and other coronaviruses.
Lim HT; Kok BH; Lim CP; Abdul Majeed AB; Leow CY; Leow CH
Biomed Eng Adv; 2022 Dec; 4():100054. PubMed ID: 36158162
[TBL] [Abstract][Full Text] [Related]
20. Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2.
Feng Y; Yuan M; Powers JM; Hu M; Munt JE; Arunachalam PS; Leist SR; Bellusci L; Adams LE; Sundaramurthy S; Shirreff LM; Mallory ML; Scooby TD; Moreno A; O'Hagan DT; Kleanthous H; Villinger FJ; Veesler D; King NP; Suthar MS; Khurana S; Baric RS; Wilson IA; Pulendran B
bioRxiv; 2023 Jan; ():. PubMed ID: 36711543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]